Paediatric (1 to 18 years old) receiving CART-T cells treatment for refractory acute leukemia or B-cell lymphoma
Adult receiving CART-T cells treatment for refractory acute leukemia or B-cell lymphoma
CMV seropositive patients
Provide written non-opposition from the patient signed by investigator
If the patient is a minor, provide written non-opposition from both parents and child (if age appropriate to collect their non-objection) or child and the legal representative in case only one parent is alive, signed by investigator
Provide written consent form signed by patient and investigator
If the patient is a minor, provide written consent form signed by investigator and both parents or signed by investigator and the legal representative in case only one parent is alive
You may not be if
CMV seronegative patients
Lack of affiliation to a social security scheme (as a beneficiary or assignee)
Patients under guardianship / curatorship
Patient under AME (state medical aid)
Clareo Health | Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis
